Applied DNA Sciences, Inc. (APDN)
NASDAQ: APDN · Real-Time Price · USD
1.680
+0.020 (1.20%)
At close: Apr 1, 2025, 4:00 PM
1.700
+0.020 (1.19%)
After-hours: Apr 1, 2025, 4:21 PM EDT
Applied DNA Sciences Balance Sheet
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2019 - 2015 |
| Cash & Equivalents | 9.29 | 6.43 | 7.15 | 15.22 | 6.55 | 7.79 | Upgrade
|
| Cash & Short-Term Investments | 9.29 | 6.43 | 7.15 | 15.22 | 6.55 | 7.79 | Upgrade
|
| Cash Growth | 176.70% | -10.08% | -53.00% | 132.12% | -15.82% | 1293.01% | Upgrade
|
| Receivables | 0.91 | 0.36 | 0.26 | 3.07 | 2.8 | 0.19 | Upgrade
|
| Inventory | 0.47 | 0.44 | 0.33 | 0.6 | 1.37 | 0.5 | Upgrade
|
| Prepaid Expenses | 0.6 | 0.82 | 0.39 | 1.06 | 0.57 | 0.6 | Upgrade
|
| Total Current Assets | 11.28 | 8.05 | 8.13 | 19.94 | 11.3 | 9.08 | Upgrade
|
| Property, Plant & Equipment | 1.25 | 1.29 | 2.08 | 2.22 | 3.02 | 1.28 | Upgrade
|
| Goodwill | - | - | - | - | - | 0.29 | Upgrade
|
| Other Intangible Assets | 2.7 | 2.7 | 2.7 | - | - | 0.61 | Upgrade
|
| Other Long-Term Assets | 0.75 | 0.75 | 0.75 | 0.1 | 0.1 | 0.1 | Upgrade
|
| Total Assets | 15.97 | 12.79 | 13.65 | 22.27 | 14.42 | 11.34 | Upgrade
|
| Accounts Payable | 1.23 | 1.17 | 1.07 | 1.74 | 2.01 | 1.25 | Upgrade
|
| Accrued Expenses | 0.38 | 0.63 | 1.2 | 1.88 | 0.98 | 0.68 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | - | - | 1.83 | Upgrade
|
| Current Portion of Leases | 0.56 | 0.55 | 0.5 | - | - | - | Upgrade
|
| Current Unearned Revenue | 0.22 | 0.06 | 0.08 | 0.56 | 0.28 | 0.51 | Upgrade
|
| Total Current Liabilities | 2.39 | 2.4 | 2.85 | 4.19 | 3.27 | 4.27 | Upgrade
|
| Long-Term Debt | - | - | - | - | - | 0.52 | Upgrade
|
| Long-Term Leases | 0.05 | 0.19 | 0.74 | - | - | - | Upgrade
|
| Long-Term Unearned Revenue | 0.19 | 0.19 | 0.19 | - | - | - | Upgrade
|
| Long-Term Deferred Tax Liabilities | 0.68 | 0.68 | 0.68 | - | - | - | Upgrade
|
| Other Long-Term Liabilities | 0.11 | 0.35 | 4.32 | 5.17 | 0.03 | 0.85 | Upgrade
|
| Total Liabilities | 3.42 | 3.82 | 8.78 | 9.36 | 3.3 | 5.63 | Upgrade
|
| Common Stock | 0.05 | 0.01 | 0 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 339.92 | 318.81 | 307.4 | 305.4 | 295.23 | 275.55 | Upgrade
|
| Retained Earnings | -327.22 | -309.67 | -302.45 | -292.5 | -284.12 | -269.84 | Upgrade
|
| Total Common Equity | 12.75 | 9.14 | 4.95 | 12.91 | 11.11 | 5.72 | Upgrade
|
| Minority Interest | -0.2 | -0.17 | -0.08 | -0 | -0 | -0.01 | Upgrade
|
| Shareholders' Equity | 12.55 | 8.97 | 4.87 | 12.91 | 11.11 | 5.71 | Upgrade
|
| Total Liabilities & Equity | 15.97 | 12.79 | 13.65 | 22.27 | 14.42 | 11.34 | Upgrade
|
| Total Debt | 0.61 | 0.74 | 1.24 | - | - | 2.35 | Upgrade
|
| Net Cash (Debt) | 8.69 | 5.69 | 5.91 | 15.22 | 6.55 | 5.44 | Upgrade
|
| Net Cash Growth | 287.52% | -3.76% | -61.13% | 132.12% | 20.48% | - | Upgrade
|
| Net Cash Per Share | 37.20 | 71.76 | 452.32 | - | - | - | Upgrade
|
| Filing Date Shares Outstanding | 1.1 | 1.05 | 0.01 | 0.01 | - | - | Upgrade
|
| Total Common Shares Outstanding | 1.08 | 0.21 | 0.01 | 0.01 | - | - | Upgrade
|
| Working Capital | 8.89 | 5.65 | 5.28 | 15.76 | 8.03 | 4.81 | Upgrade
|
| Book Value Per Share | 11.78 | 44.33 | 362.48 | 1000.22 | - | - | Upgrade
|
| Tangible Book Value | 10.05 | 6.44 | 2.25 | 12.91 | 11.11 | 4.83 | Upgrade
|
| Tangible Book Value Per Share | 9.29 | 31.24 | 164.89 | 1000.22 | - | - | Upgrade
|
| Machinery | - | 4.54 | 4.13 | 4.17 | 3.67 | 3.2 | Upgrade
|
| Leasehold Improvements | - | 0.12 | 0.12 | 0.12 | 0.12 | 0.52 | Upgrade
|
Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.